1-3 of 3
David Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years

Clinical Trials & Observations
Mohsen S. Elalfy, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohamed Badr, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Caroline Fradette, Anna Rozova, Noemi Toiber Temin, Fernando Tricta, Janet L. Kwiatkowski
Journal: Blood Advances
Blood Adv (2023) 7 (4): 611–619.
https://doi.org/10.1182/bloodadvances.2021006778
Published: 2023
Includes: Supplemental data
Journal Articles

Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study

Clinical Trials & Observations
Janet L. Kwiatkowski, Mona Hamdy, Amal El-Beshlawy, Fatma S. E. Ebeid, Mohammed Badr, Abdulrahman Alshehri, Julie Kanter, Baba Inusa, Amira A. M. Adly, Suzan Williams, Yurdanur Kilinc, David Lee, Fernando Tricta, Mohsen S. Elalfy
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1243–1254.
https://doi.org/10.1182/bloodadvances.2021004938
Published: 2022
Includes: Supplemental data
Journal Articles

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

Sheila K. Pierson, Sushila Shenoy, Ana B. Oromendia, Alexander M. Gorzewski, Ruth-Anne Langan Pai, Christopher Shield Nabel, Jason R. Ruth, Sophia A. T. Parente, Daniel J. Arenas, Mary Guilfoyle, Manjula Reddy, Michael Weinblatt, Nancy Shadick, Mark Bower, Alessia Dalla Pria, Yasufumi Masaki, Laura Katz, Jason Mezey, Philip Beineke, David Lee, Craig Tendler, Taku Kambayashi, Alexander Fosså, Frits van Rhee, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3445–3456.
https://doi.org/10.1182/bloodadvances.2020004016
Published: 2021
Includes: Supplemental data